{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:57:16Z","timestamp":1789167436817,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To examine the safety of omitting routine histopathological examination by determining the prevalence of cervical pathology in women after cervical amputation as part of pelvic organ prolapse (POP) surgery without pre-existing indication for histology and the necessity of additional treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross-sectional study was performed using data of women who underwent cervical amputation as part of POP without pre-existing indication for histopathological examination, obtained from Palga, the Dutch nationwide pathology databank, between January 1991 and January 2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main outcome measures<\/jats:title>\n            <jats:p>The prevalences of the following histological diagnoses were determined: Cervical Intraepithelial Neoplasia (CIN I\u2013III), adenocarcinomas in situ (AIS), cervical carcinomas, and other malignancies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, 14.887 patients were included in this study, with a median age of 61.4\u00a0years (SD\u2009=\u200911.7). The prevalence of CIN II+ lesions was 6.9 [95%-CI 5.6, 8.3] per 1000 women, while one cervical carcinoma (6.7 [95%-CI \u22120.6, 19.9] per 100.000 women) was reported (stage IA1 microinvasive squamous cell carcinoma).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study found a prevalence of 0.7% for CIN II+ incidental findings in women undergoing amputation of the cervix as part of POP surgery. No additional treatments were required after the final histopathological results.<\/jats:p>\n            <jats:p>The decision to omit routine histopathological examination could potentially be safe, offering the prospect of reduced healthcare costs and environmental impact. Healthcare professionals should individually assess the risks and benefits of omitting and\/or replacing routine histopathological examination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00404-025-08135-y","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T13:52:35Z","timestamp":1753365155000},"page":"1287-1294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The prevalence and clinical relevance of cervical abnormalities after an amputation of the cervix as part of prolapse surgery: a cross-sectional study"],"prefix":"10.1007","volume":"312","author":[{"given":"V\u00e9ronique V.","family":"van Cooten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"van Hamont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert G.","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luthy","family":"Alcal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud L. M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Speksnijder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"8135_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijgo.12749","volume":"145","author":"N Bhatla","year":"2019","unstructured":"Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K et al (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet 145:129\u2013135. https:\/\/doi.org\/10.1002\/ijgo.12749","journal-title":"Int J Gynecol Obstet"},{"key":"8135_CR2","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1097\/AOG.0b013e3181c2ce96","volume":"114","author":"JM Wu","year":"2009","unstructured":"Wu JM, Hundley AF, Fulton RG, Myers ER (2009) Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstet Gynecol 114:1278. https:\/\/doi.org\/10.1097\/AOG.0b013e3181c2ce96","journal-title":"Obstet Gynecol"},{"key":"8135_CR3","unstructured":"Pelvic organ prolapse in females: epidemiology, risk factors, clinical manifestations, and management\u2014UpToDate 2022. https:\/\/www.uptodate.com\/contents\/pelvic-organ-prolapse-in-females-epidemiology-risk-factors-clinical-manifestations-and-management. Accessed 14 Feb 2024"},{"issue":"184","key":"8135_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2008.08.070","volume":"200","author":"MCP Slieker-ten Hove","year":"2009","unstructured":"Slieker-ten Hove MCP, Pool-Goudzwaard AL, Eijkemans MJC, Steegers-Theunissen RPM, Burger CW, Vierhout ME (2009) Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol 200(184):e1\u2013e7. https:\/\/doi.org\/10.1016\/j.ajog.2008.08.070","journal-title":"Am J Obstet Gynecol"},{"key":"8135_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0029-7844(97)00058-6","volume":"89","author":"AL Olsen","year":"1997","unstructured":"Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501\u2013506. https:\/\/doi.org\/10.1016\/S0029-7844(97)00058-6","journal-title":"Obstet Gynecol"},{"key":"8135_CR6","unstructured":"Incision Academy (n.d.) https:\/\/academy.incision.care\/courses\/modified-manchester-repair-of-pelvic-organ-prolapse\/info\/about. Accessed 22 Oct 2022"},{"key":"8135_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018) Cancer of the cervix uteri. Int J Gynaecol Obstet 143:22\u201336. https:\/\/doi.org\/10.1002\/ijgo.12611","journal-title":"Int J Gynaecol Obstet"},{"key":"8135_CR8","unstructured":"Cervical intraepithelial neoplasia: management\u2014UpToDate 2024. https:\/\/www.uptodate.com\/contents\/cervical-intraepithelial-neoplasia-management#:~:text=Treatment%20is%20recommended.,thermoablation)%20is%20an%20acceptable%20alternative. Accessed 10 Nov 2022"},{"key":"8135_CR9","unstructured":"Management of early-stage cervical cancer\u2014UpToDate 2022. https:\/\/www.uptodate.com\/contents\/management-of-early-stage-cervical-cancer?search=management%20of%20early%20stage&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Accessed 14 Feb 2024"},{"key":"8135_CR10","unstructured":"Startpagina\u2014CIN, AIS en VAIN\u2014Richtlijn\u2014Richtlijnendatabase (n.d.) https:\/\/richtlijnendatabase.nl\/richtlijn\/cin_ais_en_vain\/startpagina_-_cin_ais_en_vain.html. Accessed 9 Nov 2022"},{"key":"8135_CR11","unstructured":"Information about cervical cancer screening|RIVM (n.d.) https:\/\/www.rivm.nl\/en\/cervical-cancer-screening-programme\/information-materials. Accessed 13 Feb 2024"},{"key":"8135_CR12","unstructured":"Monitor bevolkingsonderzoek baarmoederhalskanker (n.d.) https:\/\/iknl.nl\/kankersoorten\/baarmoederhalskanker\/onderzoek\/monitor-bevolkingsonderzoek-baarmoederhalskanker. Accessed 12 Nov 2022"},{"key":"8135_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00192-014-2413-y","volume":"26","author":"E L\u00f8wenstein","year":"2015","unstructured":"L\u00f8wenstein E, Ottesen B, Gimbel H (2015) Incidence and lifetime risk of pelvic organ prolapse surgery in Denmark from 1977 to 2009. Int Urogynecol J 26:49\u201355. https:\/\/doi.org\/10.1007\/s00192-014-2413-y","journal-title":"Int Urogynecol J"},{"key":"8135_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/gyn.2019.0029","volume":"36","author":"K Engelbredt","year":"2020","unstructured":"Engelbredt K, Glavind K, Kjaergaard N (2020) Development of cervical and uterine malignancies during follow-up after Manchester-Fothergill procedure. J Gynecol Surg 36:60\u201364. https:\/\/doi.org\/10.1089\/gyn.2019.0029","journal-title":"J Gynecol Surg"},{"key":"8135_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/AOG.0b013e3181f38599","volume":"116","author":"SS Oliphant","year":"2010","unstructured":"Oliphant SS, Jones KA, Wang L, Bunker CH, Lowder JL (2010) Trends over time with commonly performed obstetric and gynecologic inpatient procedures. Obstet Gynecol 116:926\u2013931. https:\/\/doi.org\/10.1097\/AOG.0b013e3181f38599","journal-title":"Obstet Gynecol"},{"key":"8135_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1159\/000357259","volume":"30","author":"JLP van Vliet","year":"2013","unstructured":"van Vliet JLP, van Gulik TM, Verbeek PCM (2013) Is it necessary to send gallbladder specimens for routine histopathological examination after cholecystectomy? The use of macroscopic examination. Dig Surg 30:472\u2013475. https:\/\/doi.org\/10.1159\/000357259","journal-title":"Dig Surg"},{"key":"8135_CR17","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00268-018-4619-5","volume":"42","author":"PB Olthof","year":"2018","unstructured":"Olthof PB, Metman MJH, de Krijger RR, Scheepers JJ, Roos D, Dekker JWT (2018) Routine pathology and postoperative follow-up are not cost-effective in cholecystectomy for benign gallbladder disease. World J Surg 42:3165\u20133170. https:\/\/doi.org\/10.1007\/s00268-018-4619-5","journal-title":"World J Surg"},{"key":"8135_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1155\/2007\/971816","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch ATMG, Burger G, Blauwgeers H, van de Pol A, van Krieken JHJM et al (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol Off J Int Soc Cell Oncol 29:19\u201324. https:\/\/doi.org\/10.1155\/2007\/971816","journal-title":"Cell Oncol Off J Int Soc Cell Oncol"},{"key":"8135_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/ajo.12033","volume":"53","author":"OYK Wan","year":"2013","unstructured":"Wan OYK, Cheung RYK, Chan SSC, Chung TKH (2013) Risk of malignancy in women who underwent hysterectomy for uterine prolapse. Aust N Z J Obstet Gynaecol 53:190\u2013196. https:\/\/doi.org\/10.1111\/ajo.12033","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"8135_CR20","first-page":"631","volume":"19","author":"Y Mizrachi","year":"2017","unstructured":"Mizrachi Y, Tannus S, Bar J, Sagiv R, Levy T, Condrea A et al (2017) Unexpected significant uterine pathological findings at vaginal hysterectomy despite unremarkable preoperative workup. Isr Med Assoc J IMAJ 19:631\u2013634","journal-title":"Isr Med Assoc J IMAJ"},{"key":"8135_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1479-828X.2011.01337.x","volume":"51","author":"G Mahajan","year":"2011","unstructured":"Mahajan G, Kotru M, Batra M, Gupta A, Sharma S (2011) Usefulness of histopathological examination in uterine prolapse specimens. Aust N Z J Obstet Gynaecol 51:403\u2013405. https:\/\/doi.org\/10.1111\/j.1479-828X.2011.01337.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"8135_CR22","doi-asserted-by":"publisher","unstructured":"Barakzai S, Koltun-Baker E, Melville SJF, Rangel E, Dahl M, Dancz CE (2023) Rates of unanticipated premalignant and malignant lesions at the time of hysterectomy performed for pelvic organ prolapse in an underscreened population. AJOG Glob Rep 3. https:\/\/doi.org\/10.1016\/j.xagr.2023.100217","DOI":"10.1016\/j.xagr.2023.100217"},{"key":"8135_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2273428","volume":"55","author":"O Suphattanaporn","year":"2023","unstructured":"Suphattanaporn O, Saraluck A, Mononai J, Lekskul N, Chinthakanan O (2023) Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse. Ann Med 55:2273428. https:\/\/doi.org\/10.1080\/07853890.2023.2273428","journal-title":"Ann Med"},{"key":"8135_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/jcp.55.1.67","volume":"55","author":"HA Salmon","year":"2002","unstructured":"Salmon HA, Smith JHF, Balsitis M (2002) Is microscopic assessment of macroscopically normal hysterectomy specimens necessary? J Clin Pathol 55:67\u201368. https:\/\/doi.org\/10.1136\/jcp.55.1.67","journal-title":"J Clin Pathol"},{"key":"8135_CR25","doi-asserted-by":"publisher","unstructured":"M\u00fcezzinoglu B, Doger E, Yildiz D (n.d.) The pathologic spectrum of prolapsus uteri: histopathologic evaluation of hysterectomy specimens. J Gynecol Surg. https:\/\/doi.org\/10.1089\/gyn.2005.21.133. Accessed 14 Feb 2024","DOI":"10.1089\/gyn.2005.21.133"},{"key":"8135_CR26","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s00192-021-04858-z","volume":"32","author":"RC Nicholson","year":"2021","unstructured":"Nicholson RC, Khunda A, Ballard P, Rees J, McCormick C (2021) Prevalence of histological abnormalities in hysterectomy specimens performed for prolapse. A systematic review and meta-analysis. Int Urogynecol J 32:3131\u20133141. https:\/\/doi.org\/10.1007\/s00192-021-04858-z","journal-title":"Int Urogynecol J"},{"key":"8135_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1586\/14760584.2014.990386","volume":"14","author":"D Setiawan","year":"2015","unstructured":"Setiawan D, Luttjeboer J, Westra TA, Wilschut JC, Suwantika AA, Daemen T et al (2015) The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective. Expert Rev Vaccines 14:589\u2013604. https:\/\/doi.org\/10.1586\/14760584.2014.990386","journal-title":"Expert Rev Vaccines"},{"key":"8135_CR28","unstructured":"Mc E (2022) Monitor bevolkingsonderzoek Baarmoederhalskanker 2022"},{"key":"8135_CR29","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/AOG.0000000000000286","volume":"123","author":"JM Wu","year":"2014","unstructured":"Wu JM, Matthews CA, Conover MM, Pate V, Funk MJ (2014) Lifetime risk of stress incontinence or pelvic organ prolapse surgery. Obstet Gynecol 123:1201\u20131206. https:\/\/doi.org\/10.1097\/AOG.0000000000000286","journal-title":"Obstet Gynecol"},{"issue":"507","key":"8135_CR30","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2010.01.077","volume":"202","author":"AC Frick","year":"2010","unstructured":"Frick AC, Walters MD, Larkin KS, Barber MD (2010) Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. Am J Obstet Gynecol 202(507):e1\u2013e4. https:\/\/doi.org\/10.1016\/j.ajog.2010.01.077","journal-title":"Am J Obstet Gynecol"},{"key":"8135_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"MRE McCredie","year":"2008","unstructured":"McCredie MRE, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW et al (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9:425\u2013434. https:\/\/doi.org\/10.1016\/S1470-2045(08)70103-7","journal-title":"Lancet Oncol"},{"key":"8135_CR32","unstructured":"Startpagina\u2014Cervixcarcinoom\u2014Richtlijn\u2014Richtlijnendatabase (n.d.) https:\/\/richtlijnendatabase.nl\/richtlijn\/cervixcarcinoom\/startpagina_-_cervixcarcinoom.html. Accessed 10 Aug 2023"},{"key":"8135_CR33","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1471-0528.1992.tb14440.x","volume":"99","author":"JJ Wiener","year":"1992","unstructured":"Wiener JJ, Sweetnam PM, Jones JM (1992) Long term follow up of women after hysterectomy with a history of pre-invasive cancer of the cervix. Br J Obstet Gynaecol 99:907\u2013910. https:\/\/doi.org\/10.1111\/j.1471-0528.1992.tb14440.x","journal-title":"Br J Obstet Gynaecol"},{"key":"8135_CR34","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/S2542-5196(20)30121-2","volume":"4","author":"M Lenzen","year":"2020","unstructured":"Lenzen M, Malik A, Li M, Fry J, Weisz H, Pichler P-P et al (2020) The environmental footprint of health care: a global assessment. Lancet Planet Health 4:e271\u2013e279. https:\/\/doi.org\/10.1016\/S2542-5196(20)30121-2","journal-title":"Lancet Planet Health"},{"key":"8135_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ajcp\/aqac056","volume":"158","author":"T Badrick","year":"2022","unstructured":"Badrick T (2022) The role of laboratories in reducing the carbon footprint. Am J Clin Pathol 158:322\u2013324. https:\/\/doi.org\/10.1093\/ajcp\/aqac056","journal-title":"Am J Clin Pathol"},{"key":"8135_CR36","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cmi.2022.03.034","volume":"28","author":"E Yusuf","year":"2022","unstructured":"Yusuf E, Luijendijk A, Roo-Brand G, Friedrich AW (2022) The unintended contribution of clinical microbiology laboratories to climate change and mitigation strategies: a combination of descriptive study, short survey, literature review and opinion. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 28:1245\u20131250. https:\/\/doi.org\/10.1016\/j.cmi.2022.03.034","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"8135_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.5694\/mja2.50583","volume":"212","author":"S McAlister","year":"2020","unstructured":"McAlister S, Barratt AL, Bell KJ, McGain F (2020) The carbon footprint of pathology testing. Med J Aust 212:377\u2013382. https:\/\/doi.org\/10.5694\/mja2.50583","journal-title":"Med J Aust"},{"key":"8135_CR38","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/jog.12732","volume":"41","author":"L Qiao","year":"2015","unstructured":"Qiao L, Li B, Long M, Wang X, Wang A, Zhang G (2015) Accuracy of visual inspection with acetic acid and with Lugol\u2019s iodine for cervical cancer screening: meta-analysis. J Obstet Gynaecol Res 41:1313\u20131325. https:\/\/doi.org\/10.1111\/jog.12732","journal-title":"J Obstet Gynaecol Res"},{"key":"8135_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40944-018-0221-x","volume":"16","author":"S Pankaj","year":"2018","unstructured":"Pankaj S, Kumari A, Kumari S, Choudhary V, Kumari J, Kumari A et al (2018) Evaluation of sensitivity and specificity of Pap smear, LBC and HPV in screening of cervical cancer. Indian J Gynecol Oncol 16:49. https:\/\/doi.org\/10.1007\/s40944-018-0221-x","journal-title":"Indian J Gynecol Oncol"},{"key":"8135_CR40","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.7314\/APJCP.2014.15.14.5811","volume":"15","author":"P-A Chundarat","year":"2014","unstructured":"Chundarat P-A, Suwannarurk K, Bhamarapravatana K, Pattaraarchachai J, Thaweekul Y, Mairaing K et al (2014) Incidental finding of abnormal cervical pathology in hysterectomy specimens after normal preoperative Papanicolaou smears in Thammasat University Hospital. Asian Pac J Cancer Prev 15:5811\u20135814. https:\/\/doi.org\/10.7314\/APJCP.2014.15.14.5811","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08135-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:20:10Z","timestamp":1757463610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08135-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["8135"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08135-y","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was exempt from medical ethical approval because there was no physical involvement of the women in the study, and data were not traceable to individual participants. The study was approved by the scientific committee of Palga (lzv2020-3).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that there are no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}